FDA: AuroMedics recalls Ampicillin and Sulbactam for Injection
Editor's Note
The Food and Drug Administration (FDA) on January 4 announced the recall by AuroMedics Pharma LLC (Windsor, New Jersey) of one lot of Ampicillin and Sulbactam for Injection USP 1.5 g in a single-dose vial.
The recall was issued because the lot (Lot AFOI 17001-A, Expiry date December 2018) was found to contain glass particles.
The affected lot is packaged in a carton containing 10 vials, NDC: 55150-116-20. AuroMedics shipped the entire lot to wholesalers and hospitals nationwide on February 9, 2017.
To date, AuroMedics has not received any reports of adverse events or identifiable safety concerns attributed to the product.
Posted 01/04/2018] AUDIENCE: Pharmacy, Risk Manager ISSUE: AuroMedics Pharma is voluntarily recalling one lot of Ampicillin and Sulbactam for Injection USP, 1.5 g in a Single-Dose vial (equivalent to 1 g ampicillin as the sodium salt plus 0.5 g Sulbactam as the sodium salt), to the hospital level.
Free Daily News
- Hospital-connected surgical consolidation project takes shape in Iowa
- CMS seeks stakeholder input to bolster American-made PPE, meds
- Delaware’s oversight board loses ability to modify, veto hospital spending
- Lehigh Valley Health Network opens third 'neighborhood hospital'
- Analytics firm shares data and insight about shrinkage of inpatient-only list
- Duluth, Minn., legislators call on hospitals to 'establish protections' for patients and staff against ICE
- City shuts off Georgia hospital’s water supply due to unpaid bills
- Indiana Hospital Association warns of members’ mounting financial difficulties, calls for legislative action
- Toronto clinic looks to prevent delirium in high-risk patients
- OBL-centered perspective on the 2026 ASC Final Payment Rule